Please assess the completion status of the following clinical trial:

Trial Title: A Comparison of Oral Misoprostol and Vaginal Misoprostol for Cervical Ripening and Induction of Labor

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Pregnant Female Patients greater than or equal to 18 years of age~2. Induction of labor for a single live intrauterine pregnancy~3. Greater than or equal to 37 weeks gestational age~4. Cephalic presentation~5. 20 minute reassuring fetal heart rate (reactive nonstress test (NST))~6. Bishop score based on sterile vaginal exam of less than or equal to 6, for which the cervical dilation is less than or equal to 2 cm.~7. Equal to 3 or less uterine contractions over 10 minutes~Exclusion Criteria:~1. Previous uterine scar~2. Contraindication to vaginal delivery~3. Patients with preeclampsia~4. Grand multiparty - greater than or equal to 5 live births or stillbirths~5. Premature rupture of membranes~6. Suspected intrauterine growth restriction~7. Fetal anomalies~8. Contraindication to misoprostol (history of allergy to prostaglandins, glaucoma)

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Oral misoprostol (Type: EXPERIMENTAL): oral misoprostol given 25 mcg every 2 hours
- Vaginal misoprostol (Type: ACTIVE_COMPARATOR): vaginal misoprostol given 25 mcg every 4 hours

Based on this trial design, predict the completion outcome and termination type (if applicable).